subject: CHEBI:231679

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Angioimmunoblastic T-cell lymphoma refractory

tested_intervention: unsure


subject: CHEBI:231679

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: CHEBI:231679

object_name: Mycosis fungoides refractory


subject: CHEBI:231679

object_name: Mycosis fungoides recurrent


subject: CHEBI:231679

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

tested_intervention: yes


subject: CHEBI:231679

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:88339

object_name: Solid Neoplasm


subject: CHEBI:88339

object_name: Embolism, Tumor


subject: CHEBI:88339

object_name: Neoplasm Metastasis


subject: CHEBI:88339

object_name: Metastatic Lesion


subject: CHEBI:88339

object_name: neoplasm


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: Thrombosis of blood vessel


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Metacarpal fracture


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: pancreatic neoplasm


subject: UNII:Y6BX7BL23K

object_name: exocrine pancreatic carcinoma


subject: UNII:Y6BX7BL23K

object_name: malignant pancreatic neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Hip arthropathy


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: polymorphic light eruption


subject: UMLS:C0066889

subject_name: MT-I


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Invasive bladder cancer stage II


subject: UMLS:C5784723

subject_name: NFE2L2/KEAP1/CUL3 Mutant-targeting Agent MGY825

object_name: non-small cell lung carcinoma


subject: CHEBI:50342

subject_name: L-proline residue

object_name: sarcopenia


subject: CHEBI:17203

subject_name: Proline


subject: MESH:D005223

subject_name: Fats


subject: PR:000001905

subject_name: platelet glycoprotein 4


subject: PR:000007350

subject_name: protocadherin Fat 1


subject: UniProtKB:Q07969

subject_name: CD36_RAT Platelet glycoprotein 4 (sprot)


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: gallbladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: bile duct carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: bile duct cancer


subject: UMLS:C3274547

subject_name: Sirexatamab


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C5963536

subject_name: KRAS G12D Inhibitor LY3962673

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5963536


subject: UMLS:C5963536

object_name: colorectal cancer


subject: UMLS:C5963536

object_name: colorectal carcinoma


subject: UMLS:C5963536

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:133146

subject_name: Phe-Ala

object_name: metastatic colorectal cancer


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:29013

subject_name: Fusidic acid


subject: UNII:2BT4C47RUI

subject_name: Necitumumab


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Abnormal delivery


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Constipation


subject: PUBCHEM.COMPOUND:9824461

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: Postoperative Complications


subject: PUBCHEM.COMPOUND:9824461

object_name: Postoperative Nausea


subject: PUBCHEM.COMPOUND:9824461

object_name: Hypoventilation


subject: PUBCHEM.COMPOUND:9824461

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: Vomiting


subject: CHEBI:6801

subject_name: Metformin

object_name: osteoporosis


subject: CHEBI:6801

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:6801

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:6801

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4519919

subject_name: Juvista

object_name: Cicatrization


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: prostate carcinoma


subject: CHEBI:2567

object_name: hypogonadism


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Adverse reaction to oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0000530

object_name: Childhood Solid Neoplasm


subject: UMLS:C0000530

object_name: Adult Solid Neoplasm


subject: UMLS:C0000530

object_name: Solid Neoplasm


subject: CHEBI:31596

subject_name: Febuxostat

object_name: acute urate nephropathy


subject: UNII:X6T6YN87SU

subject_name: Potassium sodium hydrogen citrate

object_name: Hyperuricemia


subject: UNII:X6T6YN87SU

object_name: Hyperuricemia, CTCAE


subject: CHEBI:28384

subject_name: vitamin K

object_name: Vascular calcification


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UNII:4A3702A96F

object_name: Lewy Bodies


subject: UMLS:C1568660

object_name: head and neck squamous cell carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Irritable heart


subject: UMLS:C3815568

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C3815568

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: pancreatic neoplasm


subject: UMLS:C3897088

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3897088

object_name: malignant pancreatic neoplasm


subject: CHEBI:36373

subject_name: vindesine

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:36373

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: sleep disorder, initiating and maintaining sleep


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Anaesthesia intubation complication


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:2569

subject_name: Alfentanil


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Insulin resistance


subject: UNII:21G64WZQ4I

subject_name: Incyclinide

object_name: Kaposi Sarcoma


subject: UNII:21G64WZQ4I

object_name: HIV infection


subject: UNII:GT5D7PW9ZR

object_name: osteoporosis


subject: UNII:GT5D7PW9ZR

object_name: Encounter due to family history of osteoporosis


subject: UNII:GT5D7PW9ZR

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:GT5D7PW9ZR

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4305944

subject_name: Strontium malonate


subject: UMLS:C4305944


subject: UMLS:C4305944


subject: UMLS:C4305944


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Dysbiosis


subject: MESH:C000628650


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: chronic otitis media


subject: PUBCHEM.COMPOUND:74030550

object_name: laryngeal disorder


subject: PUBCHEM.COMPOUND:74030550

object_name: chronic rhinosinusitis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: diffuse large B-cell lymphoma activated B-cell type


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:6ZJ8V3Q0H1


subject: UNII:6ZJ8V3Q0H1

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UNII:6ZJ8V3Q0H1

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UNII:6ZJ8V3Q0H1

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:6ZJ8V3Q0H1

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Hypotension during surgery


subject: UMLS:C4521177

object_name: Frontotemporal dementia (FTD)


subject: UMLS:C4521177

object_name: tauopathy


subject: UNII:2T1HU6069S

object_name: Pitt-Hopkins syndrome


subject: UMLS:C2715457


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: type 1 diabetes mellitus 1


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354

object_name: type 1 diabetes mellitus


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: eating disorder


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:7726

subject_name: octreotide

object_name: Carcinomatosis


subject: CHEBI:7726

object_name: carcinomatosis of unspecified behavior


subject: CHEBI:7726

object_name: intestinal obstruction


subject: CHEBI:7726

object_name: peritoneal neoplasm


subject: UMLS:C1722261

object_name: liver failure


subject: CHEBI:68575

subject_name: Indacaterol


subject: UNII:LPU25F15UQ

subject_name: Azeliragon


subject: CHEBI:140422

subject_name: VR nerve agent

object_name: Childhood Breast Carcinoma


subject: CHEBI:140422

object_name: breast carcinoma


subject: CHEBI:140422

object_name: breast cancer


subject: CHEBI:73711

subject_name: Val-Arg


subject: CHEBI:73711


subject: CHEBI:73711


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Solid Neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Dyspnea


subject: CHEBI:231425

object_name: Dyspnea, CTCAE


subject: CHEBI:231425

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:233331

subject_name: Elamipretide

object_name: Leber hereditary optic neuropathy


subject: UMLS:C4279623


subject: UMLS:C3489662


subject: CHEBI:18243

subject_name: Dopamine

object_name: Intraventricular hemorrhage of prematurity


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Disorders associated with peritoneal dialysis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:133023

subject_name: Lifitegrast

object_name: graft versus host disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage III Childhood Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Childhood Hepatocellular Carcinoma AJCC v7


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: ST-elevation myocardial infarction


subject: CHEBI:6888

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:6888

object_name: Myocardial injury


subject: CHEBI:6888

object_name: Myocardial Reperfusion Injury


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:38070

subject_name: anti-arrhythmia drug

object_name: paroxysmal atrial fibrillation


subject: CHEBI:38070

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: Small airways disease


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion


subject: PUBCHEM.COMPOUND:2307

object_name: emphysema


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:27375

subject_name: Vinblastine

object_name: renal cell adenocarcinoma


subject: CHEBI:27375

object_name: kidney cancer


subject: CHEBI:27375

object_name: renal cell carcinoma


subject: CHEBI:27375

object_name: childhood kidney cell carcinoma


subject: UMLS:C2826158

subject_name: Selectikine

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C2826158

object_name: non-Hodgkin lymphoma


subject: UMLS:C2826158

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C2826158

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:6121

subject_name: Ketamine

object_name: decubitus ulcer


subject: CHEBI:31709

subject_name: Iohexol

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C5417941

subject_name: Cannabinoid-derived Inhalation Capsule PPP011

object_name: Malignant cachexia


subject: UMLS:C5417941

object_name: Advanced cancer


subject: UMLS:C5417941

object_name: Cannabis use


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Diabetic foot ulcer


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: GTOPDB:3545

subject_name: urocortin 2

object_name: cardiovascular disorder


subject: UMLS:C0969397

subject_name: urocortin II


subject: GTOPDB:928

subject_name: urocortin 3


subject: UMLS:C0967953

subject_name: urocortin III


subject: UMLS:C0879296

subject_name: Mutant p53 Peptide Pulsed Dendritic Cell Vaccine

object_name: lung cancer


subject: UMLS:C0879296

object_name: lung neoplasm


subject: UMLS:C0879296

object_name: lung carcinoma


subject: UMLS:C0935778

subject_name: EGFR Antisense DNA

object_name: head and neck squamous cell carcinoma


subject: PR:000001256

subject_name: C-X-C chemokine receptor type 1

object_name: Metastatic Colorectal Carcinoma


subject: PR:000001256

object_name: Unresectable Rectal Adenocarcinoma


subject: PR:000001256

object_name: Stage IV Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage III Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVA Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVC Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVB Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Adenocarcinoma of colon metastatic


subject: PR:000001256

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: PR:000001256

object_name: Metastatic rectal adenocarcinoma


subject: PR:000001256

object_name: Unresectable Colon Adenocarcinoma


subject: PR:000001256

object_name: Stage IIIC Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVC Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IV Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVA Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IVB Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage III Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IIIB Colon Cancer AJCC v8


subject: PR:000001256

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:2637

subject_name: Amikacin

object_name: tuberculosis


subject: CHEBI:215747

subject_name: Tapinarof

object_name: cutaneous lupus erythematosus


subject: CHEBI:5147

subject_name: Formoterol

object_name: adult acute respiratory distress syndrome


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: non-small cell lung carcinoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:82JB1524Q6

subject_name: Ombrabulin

object_name: neoplasm


subject: UMLS:C0910081


subject: UMLS:C0662880

subject_name: Minodronate

object_name: postmenopausal osteoporosis


subject: CHEBI:50634

object_name: Effects of high altitude


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UMLS:C4053593

subject_name: Cancer Peptide Vaccine S-588410

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C4053593


subject: UMLS:C4053593

object_name: lung cancer


subject: UNII:2285XW22DR

subject_name: cixutumumab


subject: UMLS:C2699335


subject: CHEBI:6931

subject_name: Midazolam

object_name: Transient hypertension


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Childhood Neuroblastoma


subject: UNII:5S371K6132

object_name: neuroblastoma


subject: CHEBI:9927

subject_name: Valsartan

object_name: Ventricular Remodeling


subject: CHEBI:9927

object_name: impotence


subject: UMLS:C1883272

subject_name: Folate Receptor-Targeted Technetium Tc-99m EC20

object_name: osteoarthritis, knee


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Myocardial injury


subject: CHEBI:4466

object_name: Evidence of liver transplantation


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:92043599

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: small cell lung carcinoma


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Advanced Mucosal Melanoma


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C1320098

subject_name: Risperdal Consta

object_name: mental disorder


subject: UMLS:C1320098

object_name: psychiatric disorder


subject: UMLS:C1320098

object_name: Poisoning by, adverse effect of and underdosing of other psychotropic drugs


subject: CHEBI:8871

subject_name: Risperidone


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IV Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Malignant Digestive System Neoplasm


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UNII:OL741S3N8B

subject_name: irinotecan sucrosofate

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:OL741S3N8B

object_name: Metastatic Colorectal Carcinoma


subject: UNII:OL741S3N8B

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:OL741S3N8B

object_name: Metastatic Biliary Tract Carcinoma


subject: UNII:OL741S3N8B

object_name: Metastatic Bile Duct Carcinoma


subject: UNII:OL741S3N8B


subject: UNII:OL741S3N8B

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:OL741S3N8B

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UNII:OL741S3N8B

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UNII:OL741S3N8B


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:232556

object_name: Recurrent WHO Grade 4 Glioma


subject: CHEBI:232556

object_name: Recurrent WHO Grade 2 Glioma


subject: UMLS:C5448936

subject_name: Tart Cherry

object_name: Inflammation


subject: UMLS:C5448936

object_name: Increased reactive oxygen species production


subject: CHEBI:5147

subject_name: Formoterol

object_name: chronic bronchitis


subject: CHEBI:408174

subject_name: Arformoterol


subject: UMLS:C4764331

object_name: superficial urinary bladder carcinoma


subject: CHEBI:144613

subject_name: Pro-Glu-Ile


subject: CHEBI:53231

subject_name: poly(ethylene imine)


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68646

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68646

object_name: Stage IIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:68646

object_name: Stage IIIC Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:68646

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68646

object_name: Stage IIIA Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:68646

object_name: Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68646

object_name: Stage IIIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:68646

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68646

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:74460

subject_name: Clioquinol

object_name: Drug Resistant Epilepsy


subject: CHEBI:32599

object_name: Congenital hallux valgus


subject: CHEBI:32599

object_name: Acquired hallux valgus


subject: CHEBI:32599

object_name: Hallux valgus


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors

object_name: Small cell lung cancer extensive stage


subject: UMLS:C4733228

subject_name: Oshadi D

object_name: cancer


subject: UMLS:C4733228

object_name: neoplasm


subject: UMLS:C4733228

object_name: Embolism, Tumor


subject: UMLS:C4733228

object_name: Neoplasm Metastasis


subject: UMLS:C4733228

object_name: Metastasis


subject: UMLS:C4733228

object_name: Metastatic Lesion


subject: UMLS:C4733228

object_name: Tumor Mass


subject: UMLS:C4733229

subject_name: Oshadi R


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:68AYS9A614

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:68AYS9A614

object_name: salivary gland squamous cell carcinoma


subject: UNII:68AYS9A614

object_name: Untreated Metastatic Squamous Cell Carcinoma to Neck with Occult Primary


subject: UNII:68AYS9A614

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:68AYS9A614

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:68AYS9A614

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:68AYS9A614

object_name: tongue cancer


subject: UNII:68AYS9A614

object_name: tongue carcinoma


subject: UNII:68AYS9A614

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:68AYS9A614

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:68AYS9A614

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:68AYS9A614

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UNII:68AYS9A614

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:68AYS9A614

object_name: Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:68AYS9A614

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:68AYS9A614

object_name: Recurrent Salivary Gland Cancer


subject: UNII:68AYS9A614

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:68AYS9A614

object_name: Laryngeal verrucous carcinoma stage IV


subject: UNII:68AYS9A614

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UNII:68AYS9A614

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C2711999

subject_name: cediranib maleate

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C2711999

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C2711999

object_name: salivary gland squamous cell carcinoma


subject: UMLS:C2711999

object_name: Untreated Metastatic Squamous Cell Carcinoma to Neck with Occult Primary


subject: UMLS:C2711999

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C2711999

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2711999

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2711999

object_name: tongue cancer


subject: UMLS:C2711999

object_name: tongue carcinoma


subject: UMLS:C2711999

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2711999

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2711999

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2711999

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C2711999

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2711999

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: UMLS:C2711999

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2711999

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C2711999

object_name: Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2711999

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C2711999

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C2711999

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C2711999

object_name: Laryngeal verrucous carcinoma stage IV


subject: UMLS:C2711999

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UMLS:C2711999

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:4445

subject_name: Desflurane

object_name: Nausea, CTCAE_5


subject: CHEBI:4445

object_name: Nausea


subject: CHEBI:4445

object_name: Nausea, CTCAE_3


subject: CHEBI:4445

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:4445

object_name: Fatigue


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: cirrhosis, familial


subject: CHEBI:85994

object_name: Radicular Cyst


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Refractory Acute Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: UNII:4MOD1F4ENC

subject_name: Ziftomenib


subject: CHEBI:76003

subject_name: afatinib dimaleate

object_name: non-small cell lung carcinoma


subject: CHEBI:132922

object_name: female reproductive system disorder


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: metastatic prostate carcinoma


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: chronic bronchitis


subject: CHEBI:66901

object_name: bronchitis


subject: UMLS:C2741958


subject: UMLS:C2741958


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Moderate Hepatic Insufficiency


subject: CHEBI:94807

object_name: liver disorder


subject: UMLS:C0662880

subject_name: Minodronate

object_name: osteoporosis


subject: UMLS:C5780016

subject_name: PD-L1/IDO Peptide Vaccine IO102-103

object_name: melanoma


subject: UMLS:C0304475

subject_name: Potassium supplement

object_name: urolithiasis


subject: UMLS:C0304475

object_name: calculus; calyx


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: CHEBI:131389

subject_name: magnesium citrate


subject: CHEBI:131389


subject: CHEBI:131391


subject: CHEBI:131391


subject: CHEBI:62880

subject_name: Veliparib

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:62880

object_name: Metastatic BRCA Hereditary Breast Carcinoma


subject: CHEBI:62880

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:7549

subject_name: L-NAME

object_name: spinal cord injury


subject: CHEBI:7549

object_name: hypotension


subject: CHEBI:7549

object_name: Hypotension, CTCAE


subject: UMLS:C0083536

subject_name: NG-Nitroarginine Methyl Ester


subject: UMLS:C0083536


subject: UMLS:C0083536


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: escherichia coli infection


subject: UMLS:C0250480

object_name: Klebsiella infectious disease


subject: UMLS:C0250480

object_name: gram-positive bacterial infections


subject: CHEBI:95021

subject_name: pemetrexed

object_name: glioma susceptibility 1


subject: CHEBI:95021

object_name: ependymoma


subject: CHEBI:95021

object_name: childhood ependymoma


subject: CHEBI:95021

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:95021

object_name: Adult Ependymoma


subject: CHEBI:95021

object_name: Ewing sarcoma


subject: CHEBI:95021

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:95021

object_name: medulloblastoma


subject: CHEBI:95021

object_name: childhood medulloblastoma


subject: CHEBI:95021

object_name: adult medulloblastoma


subject: CHEBI:95021

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:95021

object_name: rhabdomyosarcoma


subject: CHEBI:95021

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:95021

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Spasticity, severe


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C2092209

subject_name: Baclofen Liquid Injection


subject: CHEBI:187893

subject_name: Baclofen


subject: UMLS:C5964774

subject_name: Oncolytic Adenovirus Ad5-DNX-2401

object_name: CNS disorder


subject: UMLS:C0593419

subject_name: FSME-Immun

object_name: tick-borne encephalitis


subject: UMLS:C1328192

subject_name: ADI PEG20

object_name: melanoma


subject: UMLS:C1328192

object_name: Neoplasm Metastasis


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Ventricular Remodeling


subject: UNII:C8ADC441ME

object_name: dilated cardiomyopathy 1A


subject: UNII:C8ADC441ME

object_name: Atrial Remodeling


subject: CHEBI:72296

subject_name: Apixaban

object_name: Thromboembolism of vein


subject: CHEBI:72296

object_name: leukemia


subject: CHEBI:72296

object_name: childhood leukemia


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579

object_name: adult lymphoma


subject: CHEBI:68579

object_name: lymphoma


subject: CHEBI:68579

object_name: pediatric lymphoma


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:176381

subject_name: Diosmin

object_name: varicose veins


subject: CHEBI:61606


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: CHEBI:95165

object_name: T-Cell Lymphoma


subject: CHEBI:95165

object_name: indolent B-cell non-Hodgkin lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine


subject: UNII:0NIZ8H6OL8

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:0NIZ8H6OL8


subject: PUBCHEM.COMPOUND:118753639

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:118753639

object_name: prostate cancer


subject: UMLS:C2715313


subject: UMLS:C2715313


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Myelodysplasia


subject: CHEBI:2682

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:2682

object_name: childhood myelodysplastic syndrome


subject: CHEBI:2682

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:10023


subject: CHEBI:10023


subject: CHEBI:10023


subject: CHEBI:135806

subject_name: benidipine

object_name: chronic kidney disease


subject: CHEBI:135806

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:5163

subject_name: fosinopril


subject: CHEBI:5163


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Lower urinary tract infectious disease


subject: UMLS:C5206656

subject_name: FLT3/BTK Inhibitor CG 806


subject: UMLS:C5206656

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5206656

object_name: acute myeloid leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:PVI5M0M1GW

object_name: desmoplastic small round cell tumor


subject: UNII:PVI5M0M1GW

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UNII:PVI5M0M1GW

object_name: Refractory Sarcoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UMLS:C5706412

subject_name: Pegylated TOP1 Inhibitor PEEL-224


subject: UMLS:C5706412


subject: UMLS:C5706412


subject: UMLS:C5706412

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706412

object_name: sarcoma


subject: UMLS:C5706412


subject: UMLS:C5706412

object_name: Ewing sarcoma


subject: UMLS:C5706412

object_name: pediatric osteosarcoma


subject: UMLS:C5706412

object_name: Osteosarcoma


subject: UMLS:C5706412

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C5706412

object_name: rhabdomyosarcoma


subject: UMLS:C5706412

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C5706412

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: drug allergy


subject: UNII:2P471X1Z11

object_name: drug pseudoallergy


subject: UNII:2P471X1Z11

object_name: History of - drug allergy


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: ARID1A gene mutation


subject: PR:000017295

subject_name: von Hippel-Lindau-like protein

object_name: HIV infection


subject: PR:000017295

object_name: sexually transmitted disease


subject: PR:000031824

subject_name: probable serine carboxypeptidase CPVL


subject: PR:000031824


subject: UMLS:C0003280

subject_name: Anticoagulants

object_name: pulmonary embolism


subject: UMLS:C0003280

object_name: Pulmonary thromboembolism


subject: UNII:WC1U3R1YMI

subject_name: VEPDEGESTRANT

object_name: Advanced breast cancer


subject: UMLS:C5237163

subject_name: ER alpha PROTAC Protein Degrader ARV-471


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: Multiple Trauma


subject: CHEBI:73788

object_name: Critical Illness


subject: UMLS:C0594563

subject_name: Dipeptiven


subject: UMLS:C0594563


subject: UNII:0YIV695L8O

subject_name: Calcium Laurate

object_name: Severe infection


subject: UNII:MNF86GDH3F


subject: CHEBI:30805

subject_name: Lauric acid


subject: CHEBI:16118

subject_name: Berberine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: rubeosis iridis


subject: UMLS:C2346822

subject_name: conatumumab

object_name: metastatic colorectal cancer


subject: UMLS:C2346822

object_name: rectal carcinoma


subject: UMLS:C2346822

object_name: rectal cancer


subject: UMLS:C2346822

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2346822

object_name: colon carcinoma


subject: UMLS:C2346822

object_name: colon cancer


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Torticollis


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: CHEBI:4614

subject_name: Dimethyl trisulfide

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:15891

subject_name: Taurine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:45716

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:45716

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:45716

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:45716

object_name: Prostate cancer recurrent


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Parkinson disease


subject: CHEBI:231683

subject_name: Anakinra

object_name: allergic asthma


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C0057489

subject_name: Dermatophagoides Allergens


subject: UMLS:C3853898

object_name: small cell lung carcinoma


subject: CHEBI:50858

subject_name: corticosteroid

object_name: inflammatory bowel disease


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:U7GBB0934J

object_name: viral hepatitis


subject: CHEBI:28901

subject_name: Busulfan

object_name: Hypothermia due to exposure


subject: CHEBI:28901

object_name: Hypothermia


subject: CHEBI:28901

object_name: Hypothermia, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:3223

subject_name: Buspirone


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: digestive system carcinoma


subject: UNII:M89N0Q7EQR

object_name: small intestine cancer


subject: UNII:M89N0Q7EQR

object_name: small intestine carcinoma


subject: UNII:M89N0Q7EQR

object_name: colorectal carcinoma


subject: UNII:M89N0Q7EQR

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:M89N0Q7EQR

object_name: Duodenal Cancer


subject: UNII:M89N0Q7EQR

object_name: carcinoma of duodenum


subject: UNII:M89N0Q7EQR

object_name: duodenum cancer


subject: UNII:M89N0Q7EQR

object_name: adult hepatocellular carcinoma


subject: UNII:M89N0Q7EQR

object_name: pediatric hepatocellular carcinoma


subject: UNII:M89N0Q7EQR

object_name: cholangiocarcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379

object_name: liver cancer


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:231594

subject_name: Norgestrel

object_name: type 1 diabetes mellitus 1


subject: CHEBI:231594

object_name: type 1 diabetes mellitus


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: proteinuria


subject: CHEBI:8228

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:8228

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:8228

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: hypertension


subject: UMLS:C0885467

object_name: Hypertension, CTCAE


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: allergic asthma


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: HER2 positive breast carcinoma


subject: UNII:CS4U38E731

subject_name: Nigella sativa oil

object_name: osteoarthritis, knee


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Hernia of the abdominal wall


subject: CHEBI:46195

object_name: Hernia


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: MESH:C500671

object_name: BREAST CANCER NOS METASTATIC RECURRENT


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: adult acute myeloid leukemia


subject: UNII:T4H8FMA7IM

object_name: childhood acute myeloid leukemia


subject: UNII:T4H8FMA7IM

object_name: acute myeloid leukemia


subject: UNII:RYI4401DTM

subject_name: INDACATEROL ACETATE

object_name: asthma


subject: UMLS:C5433054

subject_name: Indacaterol acetate


subject: PUBCHEM.COMPOUND:136170999

subject_name: FOLFIRI regimen

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C3853885


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: prostate disorder


subject: PUBCHEM.COMPOUND:121489720

object_name: Male Urogenital Diseases


subject: PUBCHEM.COMPOUND:121489720

object_name: male reproductive system disorder


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: prostate carcinoma


subject: UNII:96265TNH2R

object_name: prostate cancer


subject: UNII:96265TNH2R

object_name: castration-resistant prostate carcinoma


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: poisoning


subject: CHEBI:28748

object_name: overall survival


subject: PUBCHEM.COMPOUND:131751553

subject_name: Morellinol

object_name: hypobetalipoproteinemia


subject: CHEBI:176233

subject_name: Tocophersolan


subject: CHEBI:18145

subject_name: Vitamin E


subject: UNII:O03S90U1F2

subject_name: Tocofersolan


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: Perianal warts


subject: UNII:T432289GYZ

object_name: Genital warts


subject: UMLS:C0919390

subject_name: Nolvadex

object_name: Childhood Breast Carcinoma


subject: UMLS:C0919390

object_name: breast carcinoma


subject: UMLS:C0919390

object_name: breast cancer


subject: CHEBI:143658

object_name: hemangioma


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C3274911

subject_name: Gliolan

object_name: ulcerative colitis


subject: UMLS:C3274911

object_name: inflammatory bowel disease 1


subject: PR:000011357

subject_name: NPC intracellular cholesterol transporter 2

object_name: type 2 diabetes mellitus


subject: UniProtKB:P03114

subject_name: VE1_HPV16 Replication protein E1 (sprot)


subject: CHEBI:156296


subject: PR:000003866

subject_name: allograft inflammatory factor 1


subject: CHEBI:86327

subject_name: antifungal drug

object_name: tinea pedis


subject: UMLS:C0003308

subject_name: Antifungal Agents


subject: CHEBI:3764

subject_name: Clotrimazole


subject: UNII:7LBRZUYSHU

subject_name: Branebrutinib

object_name: EXCESS LMW-DNA


subject: UNII:7LBRZUYSHU

object_name: Primary Sjögren's syndrome


subject: UNII:7LBRZUYSHU

object_name: Autoimmunity


subject: UNII:7LBRZUYSHU

object_name: Autoimmune Disorder, CTCAE


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Severe Sepsis


subject: CHEBI:30742

subject_name: macrogol

object_name: ablepharon macrostomia syndrome


subject: CHEBI:30742

object_name: Diminished mental health


subject: CHEBI:30742

object_name: Elliptocytosis


subject: CHEBI:30742

object_name: Cirrhosis


subject: CHEBI:30742

object_name: liver cirrhosis


subject: CHEBI:91464

object_name: indolent systemic mastocytosis


subject: CHEBI:63452

subject_name: Midostaurin


subject: PR:000011651

subject_name: opticin

object_name: inflammatory bowel disease


subject: PR:000032354

subject_name: SUN domain-containing ossification factor


subject: UMLS:C3491843

object_name: pervasive developmental disorder


subject: UMLS:C3491843

object_name: autism


subject: UMLS:C3491843

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: cocaine dependence


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:231679

subject_name: ipilimumab

object_name: myelofibrosis


subject: CHEBI:231679

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:231679

object_name: acute myeloid leukemia


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: precancerous condition


subject: UMLS:C0034862

object_name: Non-Cancer Diagnosis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: HIV infection


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Anal cancer recurrent


subject: CHEBI:45716

object_name: recurrent gastric cancer


subject: CHEBI:45716

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:45716

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:45716

object_name: Salivary gland cancer stage IV


subject: CHEBI:45716

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:45716

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:45716

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:45716

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:45716

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:45716

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:45716

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:45716

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45716

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45716

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45716

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:45716

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:45716

object_name: Anal cancer stage IV


subject: CHEBI:45716

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:45716

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:45716

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:45716

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:45716

object_name: Ovarian cancer stage IV


subject: CHEBI:45716

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:45716

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:45716

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:45716

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:45716

object_name: stage IV esophageal cancer


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: neoplasm


subject: CHEBI:4636

object_name: Childhood Solid Neoplasm


subject: CHEBI:4636

object_name: Adult Solid Neoplasm


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: cancer


subject: CHEBI:63611


subject: CHEBI:63611


subject: CHEBI:63611


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Compulsion


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: allergic bronchopulmonary aspergillosis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C3273205

subject_name: AVL 292

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3273205

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C3273205

object_name: B-cell neoplasm


subject: UMLS:C3273205

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C3812144

subject_name: Gelsemium sempervirens whole extract

object_name: anxiety


subject: UMLS:C3812144

object_name: anxiety disorder


subject: UMLS:C3812144

object_name: Anxiety symptoms


subject: UMLS:C3812144

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C3812144

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:94291

object_name: pancreatic neoplasm


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5555042

subject_name: Danvilostomig


subject: GTOPDB:5962

subject_name: dovitinib

object_name: von Hippel-Lindau disease


subject: CHEBI:50859

object_name: lung cancer


subject: CHEBI:50859

object_name: lung neoplasm


subject: CHEBI:50859

object_name: lung carcinoma


subject: GTOPDB:12990

subject_name: sintilimab

object_name: cervical cancer


subject: GTOPDB:12990

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C2985186

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: CHEBI:91083

subject_name: Romiplostim

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1505595


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: medullary thyroid gland carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: uterine cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: tumor of uterus


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: carcinosarcoma


subject: UMLS:C3274547

subject_name: Sirexatamab


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: GTOPDB:12347

subject_name: penpulimab

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: GTOPDB:12347

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: CHEBI:73803

subject_name: Ala-Asp

object_name: primary central nervous system lymphoma


subject: CHEBI:27666

subject_name: Dactinomycin


subject: UMLS:C1630418

subject_name: AD Substance


subject: CHEBI:64073

object_name: Weight Gain


subject: CHEBI:64073

object_name: Weight Gain, CTCAE


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: CHEBI:64073

object_name: Diabetic peripheral neuropathy


subject: UNII:9P1872D4OL


subject: CHEBI:33569

subject_name: noradrenaline

object_name: metabolic acidosis


subject: CHEBI:33569

object_name: acidosis


subject: CHEBI:33569

object_name: Acidosis, CTCAE


subject: CHEBI:33569

object_name: Maternal Hypotension


subject: CHEBI:33569

object_name: Newborn affected by Cesarean delivery


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:18357


subject: UMLS:C1450556

subject_name: aviscumine

object_name: metastatic colorectal cancer


subject: RXCUI:1670307

subject_name: tipiracil / trifluridine Oral Product

object_name: pancreatic ductal adenocarcinoma


subject: RXCUI:1670307

object_name: pancreatic neoplasm


subject: RXCUI:1670307

object_name: exocrine pancreatic carcinoma


subject: RXCUI:1670307

object_name: malignant pancreatic neoplasm


subject: CHEBI:4911

subject_name: Etoposide

object_name: Carcinoma breast stage IV


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Adult Penile Carcinoma


subject: UNII:6QVL057INT

object_name: penis carcinoma


subject: UNII:6QVL057INT

object_name: penile cancer


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:181906

subject_name: Polydextrose

object_name: Constipation


subject: CHEBI:181906

object_name: Constipation, CTCAE


subject: CHEBI:181906

object_name: Gastrointestinal dysfunction


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: medulloblastoma


subject: PUBCHEM.COMPOUND:3062

object_name: childhood medulloblastoma


subject: PUBCHEM.COMPOUND:3062

object_name: adult medulloblastoma


subject: PUBCHEM.COMPOUND:3062

object_name: medulloblastoma non-WNT/non-SHH


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:4551


subject: UNII:VUW370O5QE

subject_name: Cancidas

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:VUW370O5QE

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin


subject: PUBCHEM.COMPOUND:3035406


subject: UMLS:C1145191

subject_name: INJECTION, CASPOFUNGIN ACETATE, 5 MG


subject: UMLS:C1145191


subject: UMLS:C0935942


subject: UMLS:C0935942


subject: UMLS:C1831973

subject_name: Alpha-type-1 Polarized Dendritic Cells

object_name: Refractory Melanoma


subject: UMLS:C1831973

object_name: HLA-A2 Positive Cells Present


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: UMLS:C4745152

subject_name: PD-1 Ligand Inhibitor


subject: UMLS:C4745152


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UMLS:C4086713


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: PUBCHEM.COMPOUND:135537060


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N


subject: CHEBI:91400

subject_name: Afatinib

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:192614

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:192614

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: perinatal asphyxia


subject: PUBCHEM.COMPOUND:435949


subject: PUBCHEM.COMPOUND:435949


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: osteoporosis


subject: DRUGBANK:DB19249

object_name: Encounter due to family history of osteoporosis


subject: DRUGBANK:DB19249

object_name: Osteoporosis, CTCAE 5.0


subject: DRUGBANK:DB19249

object_name: Osteoporosis, CTCAE 3.0


subject: DRUGBANK:DB19249

object_name: sarcopenia


subject: CHEBI:15365

subject_name: Aspirin

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:15365

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:15365

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: long QT syndrome


subject: CHEBI:63611

object_name: familial long QT syndrome


subject: CHEBI:63611

object_name: Prolonged QT interval


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: aneurysm


subject: CHEBI:25681

object_name: endocrine system disorder


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Ventricular Dysfunction


subject: UMLS:C5555135

subject_name: KRAS G12C Inhibitor D-1553

object_name: colorectal cancer


subject: UMLS:C5555135

object_name: colorectal carcinoma


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: Adult Solid Neoplasm


subject: UMLS:C1550146


subject: UMLS:C1550146


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba

object_name: Childhood Breast Carcinoma


subject: UNII:19FUJ2C58T

object_name: breast carcinoma


subject: UNII:19FUJ2C58T

object_name: breast cancer


subject: UNII:19FUJ2C58T

object_name: neurotoxicity


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: UMLS:C3531686


subject: UMLS:C3531686


subject: UMLS:C3531686


subject: UMLS:C5432289

subject_name: GP2 peptide


subject: UMLS:C5432289


subject: UMLS:C5432289


subject: UNII:W6I5QDT7QI

subject_name: Netarsudil

object_name: low tension glaucoma


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:56776542

object_name: inflammatory bowel disease 1


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UNII:571045EIM4


subject: UMLS:C3827124


subject: UMLS:C3827124


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: gastric neoplasm


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UNII:XEW3CUX2ZE

subject_name: DESACYL GHRELIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:XEW3CUX2ZE

object_name: obesity


subject: UNII:XEW3CUX2ZE

object_name: Obesity, CTCAE


subject: UNII:XEW3CUX2ZE

object_name: alcohol abuse


subject: UNII:XEW3CUX2ZE

object_name: alcohol dependence


subject: UMLS:C0965048

subject_name: ghrelin, des-n-octanoyl


subject: UMLS:C0965048


subject: UMLS:C0965048


subject: UMLS:C0965048


subject: UMLS:C0965048


subject: CHEBI:64073


subject: CHEBI:64073


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UNII:1CIV2UMO40

subject_name: Minnelide

object_name: Stomach cancer


subject: UNII:1CIV2UMO40

object_name: gastric cancer


subject: UNII:4I9I5X3Z6N

subject_name: VUDALIMAB

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C4725753

subject_name: Vudalimab


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Central neuropathic pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: MESH:C078788

subject_name: ALVAC vaccine

object_name: HIV Seronegativity


subject: CHEBI:141442

subject_name: Met-Asn


subject: CHEBI:18291

subject_name: manganese atom


subject: PR:000004926

subject_name: carbonic anhydrase 9


subject: PUBCHEM.COMPOUND:145705873

subject_name: Chlorotoxin

object_name: Recurrent Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:145705873

object_name: Recurrent Glioblastoma


subject: PUBCHEM.COMPOUND:145705873

object_name: Recurrent Malignant Glioma


subject: PUBCHEM.COMPOUND:145705873

object_name: Recurrent WHO Grade 2 Glioma


subject: PUBCHEM.COMPOUND:145705873

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEMBL.COMPOUND:CHEMBL4298122

subject_name: CHLOROTOXIN


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: CHEBI:77323

subject_name: Ethoxyquin


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:141435

subject_name: Glu-Gln


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Vertical Disease Transmission


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: CHEBI:16302


subject: CHEBI:16302

object_name: HIV infection


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: CHEBI:17579

subject_name: Beta carotene


subject: CHEBI:17579


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:46245

object_name: sarcopenia


subject: CHEBI:46245

object_name: Frailty


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: chronic kidney disease


subject: CHEBI:15927


subject: UNII:478ZV54680

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:1GAJ98SC2X


subject: HMDB:HMDB0014869

subject_name: Nateglinide

object_name: Insulin resistance


subject: HMDB:HMDB0014869

object_name: Impaired fasting glucose


subject: CHEBI:49165

object_name: eosinophilic esophagitis


subject: CHEBI:49165

object_name: Eosinophilic infiltration of the esophagus


subject: CHEMBL.COMPOUND:CHEMBL5314729

subject_name: BRENETAFUSP

object_name: Advanced Melanoma


subject: UMLS:C5856921

subject_name: Brenetafusp


subject: UNII:5W6YA9PKKH

subject_name: INDINAVIR

object_name: AIDS


subject: CHEBI:44032

subject_name: Indinavir


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Androgen excess


subject: CHEBI:60648

object_name: Irregular menstruation


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:10033

subject_name: Warfarin

object_name: heparin-induced thrombocytopenia


subject: CHEBI:6121

subject_name: Ketamine

object_name: severe traumatic brain injury


subject: CHEBI:6121

object_name: Intracranial Hemorrhage, Hypertensive


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915

object_name: intracranial hypertension


subject: PUBCHEM.COMPOUND:133090

subject_name: Talnetant

object_name: irritable bowel syndrome


subject: UNII:CZ3T9T146K


subject: UMLS:C3838813

subject_name: BRAF inhibitor (product)

object_name: melanoma


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C1446777

object_name: aplastic anemia


subject: UMLS:C1446777

object_name: idiopathic aplastic anemia


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: spinal cord injury


subject: CHEBI:146178

object_name: Central neuropathic pain


subject: CHEBI:146178

object_name: Allodynia


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: childhood acute lymphoblastic leukemia


subject: UNII:D733ET3F9O

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:Q91187K011

object_name: anemia


subject: UNII:Q91187K011

object_name: Anemia, CTCAE


subject: CHEBI:144421

subject_name: ferric citrate


subject: CHEBI:144421


subject: CHEBI:144421


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Myelodysplasia


subject: CHEBI:50217

subject_name: selegiline

object_name: Cognitive impairment


subject: CHEBI:91541

object_name: Renal Colic, CTCAE


subject: CHEBI:91541

object_name: renal colic


subject: PUBCHEM.COMPOUND:160883

subject_name: Butylscopolamine


subject: PUBCHEM.COMPOUND:160883


subject: CHEBI:64064

subject_name: Salmeterol

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:140529927

subject_name: Magnesium threonate

object_name: mood (physical finding)


subject: PUBCHEM.COMPOUND:140529927

object_name: anxiety


subject: PUBCHEM.COMPOUND:140529927

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:140529927

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:140529927

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:140529927

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C3661433

subject_name: magnesium threonate


subject: UMLS:C3661433


subject: UMLS:C3661433


subject: UMLS:C3661433


subject: UMLS:C3661433


subject: UMLS:C3661433


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: leukemia


subject: CHEBI:28887

object_name: childhood leukemia


subject: CHEBI:28887

object_name: adult lymphoma


subject: CHEBI:28887

object_name: lymphoma


subject: CHEBI:28887

object_name: pediatric lymphoma


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Obstructive sleep apnea of adult


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:119915

subject_name: Fentanyl

object_name: precancerous condition


subject: CHEBI:119915

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:119915


subject: CHEBI:119915

object_name: myeloproliferative neoplasm


subject: CHEBI:119915

object_name: lymphoproliferative syndrome


subject: CHEBI:119915

object_name: Myelodysplasia


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: UMLS:C1614968

subject_name: Sativex

object_name: cerebral palsy


subject: UMLS:C1328728

object_name: anus cancer


subject: UMLS:C1328728

object_name: anal carcinoma


subject: UMLS:C1328728

object_name: colorectal cancer


subject: UMLS:C1328728

object_name: colorectal carcinoma


subject: UMLS:C1328728

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1328728

object_name: Stomach cancer


subject: UMLS:C1328728

object_name: gastric cancer


subject: UMLS:C1328728

object_name: pancreatic neoplasm


subject: UMLS:C1328728

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1328728

object_name: malignant pancreatic neoplasm


subject: UMLS:C1328728

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: gallbladder cancer


subject: UMLS:C1328728

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C1328728

object_name: gallbladder carcinoma


subject: CHEBI:52172

subject_name: Nilotinib

object_name: appendix cancer


subject: CHEBI:52172

object_name: appendix carcinoma


subject: CHEBI:52172

object_name: peritoneal carcinomatosis


subject: CHEBI:52172

object_name: ovarian cancer


subject: CHEBI:52172

object_name: ovarian neoplasm


subject: CHEBI:52172

object_name: ovarian carcinoma


subject: CHEBI:52172

object_name: appendiceal neoplasm


subject: CHEBI:52172

object_name: peritoneal neoplasm


subject: CHEBI:52172

object_name: colorectal neoplasm


subject: CHEBI:52172

object_name: female reproductive system neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine

object_name: bacterial infectious disease


subject: UMLS:C0065828

object_name: viral disease


subject: UNII:E37CY3439H

subject_name: LACTOBACILLUS SAKEI PROBIO-65

object_name: chronic rhinosinusitis


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: melanoma


subject: GTOPDB:11552

subject_name: ziltivekimab

object_name: acute myocardial infarction


subject: GTOPDB:11552

object_name: Cardiovascular Risk


subject: CHEMBL.COMPOUND:CHEMBL4297732

subject_name: ZILTIVEKIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297732


subject: UMLS:C5419333


subject: UMLS:C5419333


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Cervix carcinoma recurrent


subject: CHEBI:4672

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: MESH:C560489

subject_name: MVA vaccine

object_name: EBV Infection


subject: MESH:C560489

object_name: nasopharyngeal neoplasm


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Prader-Willi syndrome


subject: UMLS:C5557249

subject_name: Anti-ALK-1 Monoclonal Antibody GT90001

object_name: Metastatic hepatocellular carcinoma


subject: UMLS:C5557249

object_name: Polysubstance dependence


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C5557657

object_name: prostate cancer


subject: UMLS:C5557657

object_name: prostate neoplasm


subject: UMLS:C5783614

object_name: HER2 positive colorectal cancer


subject: UMLS:C5783614

object_name: HER2-positive gastric cancer


subject: UMLS:C5783614

object_name: HER2 positive breast carcinoma


subject: UMLS:C5783614

object_name: HER2 low breast cancer


subject: UMLS:C4053648

subject_name: EC-18 cpd

object_name: Febrile Neutropenia


subject: UMLS:C4053648

object_name: Febrile Neutropenia, CTCAE


subject: UNII:CF19SF72O5

subject_name: OLVIMULOGENE NANIVACIREPVEC

object_name: primary peritoneal carcinoma


subject: UNII:CF19SF72O5

object_name: Primary Peritoneal Cancer


subject: UNII:CF19SF72O5

object_name: fallopian tube carcinoma


subject: UNII:CF19SF72O5

object_name: fallopian tube cancer


subject: UNII:CF19SF72O5

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:CF19SF72O5

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:CF19SF72O5

object_name: Ovarian clear cell carcinoma


subject: UNII:CF19SF72O5

object_name: ovarian clear cell cancer


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: TINNITUS CHRONIC


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:Y180U02GSB

object_name: diabetes mellitus


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: UMLS:C0770694

object_name: myeloproliferative neoplasm


subject: UMLS:C0770694

object_name: benign neoplasm


subject: UMLS:C0770694

object_name: adult lymphoma


subject: UMLS:C0770694

object_name: lymphoma


subject: UMLS:C0770694

object_name: pediatric lymphoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: concussion


subject: CHEBI:28939

object_name: Mild Traumatic Brain Injury


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: osteoradionecrosis


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: myocardial infarction


subject: CHEBI:49040

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:49040

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: Adhesive Capsulitis


subject: PUBCHEM.COMPOUND:54671203

object_name: frozen shoulder


subject: PUBCHEM.COMPOUND:54671203

object_name: bursitis


subject: PUBCHEM.COMPOUND:54671203

object_name: Adhesive capsulitis of unspecified shoulder


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEMBL.COMPOUND:CHEMBL4594356

object_name: colorectal neoplasm


subject: UMLS:C4053572


subject: UMLS:C4053572


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Metastatic malignant neoplasm to bone marrow


subject: PUBCHEM.COMPOUND:14907381

object_name: Disseminated Intravascular Coagulation Related to COVID-19


subject: PUBCHEM.COMPOUND:14907381

object_name: disseminated intravascular coagulation


subject: PUBCHEM.COMPOUND:14907381

object_name: Disseminated Intravascular Coagulation, CTCAE


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:74224

object_name: pancreatic neoplasm


subject: CHEBI:74224

object_name: exocrine pancreatic carcinoma


subject: CHEBI:74224

object_name: malignant pancreatic neoplasm


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:131701

object_name: obesity


subject: CHEBI:131701

object_name: Obesity, CTCAE


subject: CHEBI:131701

object_name: Heart Disease Risk Factors


subject: CHEBI:131701

object_name: circadian rhythm sleep disorder


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: schizophrenia


subject: CHEBI:33379

subject_name: erbium


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: PR:000007204

subject_name: estrogen receptor


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Severe Aplastic Anemia


subject: CHEBI:93775

object_name: severe aplastic anemia


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:127236

object_name: Autoimmunity


subject: PUBCHEM.COMPOUND:127236

object_name: Sicca Syndrome


subject: PUBCHEM.COMPOUND:127236

object_name: Acute systemic lupus erythematosus


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: PR:000001406


subject: PR:000001406


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Hepatic impairment


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: malignant tumor of nasopharynx


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:32150

object_name: mixed connective tissue disease


subject: CHEBI:132112


subject: CHEBI:15738

subject_name: Staurosporine


subject: CHEBI:15738

object_name: calcinosis


subject: MESH:D016324

subject_name: Sequence Tagged Sites


subject: MESH:D016324


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)


subject: CHEBI:75275


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: IgA monoclonal gammopathy of uncertain significance


subject: CHEBI:135207

subject_name: Clofedanol

object_name: fetal growth restriction


subject: CHEBI:135207

object_name: Fetal Growth Retardation, CTCAE


subject: CHEBI:135207

object_name: Light for dates


subject: CHEBI:135207

object_name: Premature birth


subject: CHEBI:135207

object_name: premature birth (history)


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:231693

subject_name: Capmatinib

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:60802

subject_name: ropivacaine

object_name: female reproductive system disorder


subject: UMLS:C5556706

subject_name: Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5556706

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5556706

object_name: non-small cell lung carcinoma


subject: UMLS:C5556706

object_name: cervical adenocarcinoma


subject: UMLS:C5556706

object_name: endocervical carcinoma


subject: UMLS:C5556706

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5556706

object_name: clear cell renal carcinoma


subject: UMLS:C5556706

object_name: renal cell adenocarcinoma


subject: UMLS:C5556706

object_name: renal cell carcinoma


subject: UMLS:C5556706

object_name: carcinoma of esophagus


subject: UMLS:C5556706

object_name: esophageal cancer


subject: UMLS:C5556706

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5556706

object_name: neoplasm of esophagus


subject: UMLS:C5556706

object_name: colorectal cancer


subject: UMLS:C5556706

object_name: colorectal carcinoma


subject: UMLS:C5556706

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5556706

object_name: cholangiocarcinoma


subject: UMLS:C5556706

object_name: cervical cancer


subject: UMLS:C5556706

object_name: cervical carcinoma


subject: UMLS:C5556706

object_name: Stomach cancer


subject: UMLS:C5556706

object_name: gastric cancer


subject: UMLS:C5556706

object_name: ovarian cancer


subject: UMLS:C5556706

object_name: ovarian neoplasm


subject: UMLS:C5556706

object_name: ovarian carcinoma


subject: UMLS:C5556706

object_name: Childhood Breast Carcinoma


subject: UMLS:C5556706

object_name: breast carcinoma


subject: UMLS:C5556706

object_name: breast cancer


subject: UMLS:C5556706

object_name: Mesothelioma


subject: UMLS:C5556706

object_name: mesothelial neoplasm


subject: UMLS:C5556706

object_name: malignant mesothelioma


subject: UMLS:C5556706

object_name: glioblastoma


subject: UMLS:C5556706

object_name: Childhood Glioblastoma


subject: UMLS:C5556706

object_name: adult glioblastoma


subject: UMLS:C5556706

object_name: melanoma


subject: UMLS:C3827112


subject: UMLS:C3827112


subject: UMLS:C3827112


subject: CHEBI:6704

subject_name: Mebendazole

object_name: ulcerative colitis


subject: CHEBI:6704

object_name: inflammatory bowel disease 1


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: heart disorder


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Shoulder Injuries


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Duchenne muscular dystrophy


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: invasive breast carcinoma


subject: CHEBI:92076

object_name: ductal breast carcinoma in situ


subject: CHEBI:3310

subject_name: Calcium acetate

object_name: Vasodilation disorder


subject: CHEBI:3310

object_name: Vascular Stiffness


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: Stomach cancer


subject: CHEBI:15698

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Eisenmenger syndrome


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: aortic valve disease 2


subject: CHEBI:5001

object_name: aortic stenosis


subject: CHEBI:5001

object_name: aortic valve disease 3


subject: CHEBI:5001

object_name: Stenosis of aorta


subject: CHEBI:60791

subject_name: Xylocard

object_name: Fractured forearm bone


subject: CHEBI:6456

subject_name: Lidocaine


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: PUBCHEM.COMPOUND:1805

object_name: Infant Acute Undifferentiated Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: acute undifferentiated leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: T-Cell Lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:17650

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:17650


subject: CHEBI:17650

object_name: acute myeloid leukemia


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: UNII:8ZHS5657EH

subject_name: Tagraxofusp


subject: UNII:8ZHS5657EH

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:8ZHS5657EH


subject: UNII:8ZHS5657EH

object_name: acute lymphoblastic leukemia


subject: UNII:8ZHS5657EH


subject: UNII:8ZHS5657EH


subject: UNII:8ZHS5657EH


subject: UNII:8ZHS5657EH


subject: UNII:8ZHS5657EH

object_name: Miller-Dieker lissencephaly syndrome


subject: UNII:8ZHS5657EH

object_name: myoclonic dystonia 11


subject: UNII:8ZHS5657EH

object_name: acute biphenotypic leukemia


subject: UNII:8ZHS5657EH

object_name: mixed phenotype acute leukemia


subject: UNII:8ZHS5657EH

object_name: acute leukemia of ambiguous lineage


subject: UNII:8ZHS5657EH

object_name: Infant Acute Undifferentiated Leukemia


subject: UNII:8ZHS5657EH

object_name: acute undifferentiated leukemia


subject: UNII:8ZHS5657EH

object_name: B-cell neoplasm


subject: UNII:8ZHS5657EH

object_name: T-Cell Lymphoma


subject: UNII:8ZHS5657EH

object_name: Hodgkin Disease


subject: UNII:8ZHS5657EH

object_name: Adult Hodgkin Lymphoma


subject: UNII:8ZHS5657EH

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C1831974

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C1831974


subject: UMLS:C1831974

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C1831974


subject: UMLS:C1831974

object_name: lymphoblastic lymphoma


subject: UMLS:C1831974

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C1831974

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C1831974

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UMLS:C1831974

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C1831974

object_name: myoclonic dystonia 11


subject: UMLS:C1831974

object_name: acute biphenotypic leukemia


subject: UMLS:C1831974

object_name: mixed phenotype acute leukemia


subject: UMLS:C1831974

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C1831974

object_name: Infant Acute Undifferentiated Leukemia


subject: UMLS:C1831974

object_name: acute undifferentiated leukemia


subject: UMLS:C1831974

object_name: B-cell neoplasm


subject: UMLS:C1831974

object_name: T-Cell Lymphoma


subject: UMLS:C1831974

object_name: Hodgkin Disease


subject: UMLS:C1831974

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C1831974

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:44915

subject_name: Propofol

object_name: Pain, Intractable


subject: CHEBI:40237

subject_name: Sitagliptin

object_name: Glucose Intolerance, CTCAE


subject: UMLS:C0717811

subject_name: PedvaxHIB

object_name: Haemophilus influenzae Type b Infection


subject: UMLS:C4506397

subject_name: Vaxelis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Colon Neoplasm


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Edema


subject: UMLS:C0306371

subject_name: Humulin R

object_name: heart valve disorder


subject: UMLS:C0306371

object_name: Ventricular Dysfunction


subject: CHEBI:8382

subject_name: Prednisone

object_name: Takayasu arteritis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5203017

subject_name: G-Series Nerve Agent GB

object_name: Fat burn


subject: UMLS:C5203017

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5203017

object_name: obesity


subject: UMLS:C5203017

object_name: Obesity, CTCAE


subject: CHEBI:3892

subject_name: Corticotropin

object_name: LUPUS ERYTHEMATOSUS SYSTEMIC EXACERBATION


subject: UMLS:C5201181

subject_name: H.P. acthar gel


subject: PUBCHEM.COMPOUND:129027150

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:129027150

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:EDZ8BK9GK2


subject: UNII:EDZ8BK9GK2


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: Androgen excess


subject: CHEBI:229764

subject_name: Selinexor

object_name: glioma


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: bronchiectasis


subject: UNII:6V860VW8AO

subject_name: Ruboxistaurin mesylate

object_name: diabetes mellitus


subject: UMLS:C0879272

object_name: myeloproliferative neoplasm


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:3380

subject_name: Captopril

object_name: Heart Failure, CTCAE


subject: UMLS:C0006938

subject_name: captopril


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C5399992

object_name: High Risk Myelodysplastic Syndrome


subject: UMLS:C5399992

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5399992


subject: DRUGBANK:DB13932

subject_name: Voretigene neparvovec

object_name: Leber congenital amaurosis


subject: MESH:C417427

subject_name: colestimide

object_name: hyperphosphatemia


subject: MESH:C417427

object_name: Serum phosphate concentrations above normal (finding)


subject: MESH:C417427

object_name: Hyperphosphatemia, CTCAE


subject: MESH:C417427


subject: MESH:C417427


subject: CHEBI:33704

subject_name: Amino acid

object_name: isolated tracheo-esophageal fistula


subject: CHEBI:33704


subject: CHEBI:33704

object_name: Diaphragmatic hernia without mention of obstruction or gangrene


subject: CHEBI:33704

object_name: congenital diaphragmatic hernia


subject: CHEBI:33704

object_name: isolated Pierre-Robin syndrome


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C2917660

subject_name: Amino Acid [EPC]


subject: UMLS:C2917660


subject: UMLS:C2917660


subject: UMLS:C2917660


subject: UMLS:C2917660


subject: CHEBI:16857

subject_name: Threonine


subject: CHEBI:16857


subject: CHEBI:16857


subject: CHEBI:16857


subject: CHEBI:16857


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: UNII:L24XJN68OW

object_name: ocular melanoma


subject: UNII:L24XJN68OW

object_name: uveal melanoma


subject: UNII:L24XJN68OW

object_name: skin melanoma


subject: CHEBI:58097

object_name: Stomach cancer


subject: CHEBI:58097

object_name: gastric cancer


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17688

subject_name: Nicotine

object_name: substance withdrawal syndrome


subject: CHEBI:75722

subject_name: Tramadol

object_name: cesarean section; complications


subject: PUBCHEM.COMPOUND:25127414

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:25127414

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:25127414

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:25127414

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:25127414

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:25127414

object_name: adult glioblastoma


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: type 2 diabetes mellitus


subject: CHEBI:50733

subject_name: nutraceutical

object_name: food allergy


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UNII:AG9MHG098Z

object_name: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UNII:AG9MHG098Z

object_name: Large B-cell lymphoma with IRF4 rearrangement


subject: UNII:AG9MHG098Z

object_name: Refractory Intravascular Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z

object_name: Recurrent Intravascular Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:AG9MHG098Z

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:AG9MHG098Z

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:AG9MHG098Z

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UNII:AG9MHG098Z

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:AG9MHG098Z

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:AG9MHG098Z

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:AG9MHG098Z

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:AG9MHG098Z

object_name: primary cutaneous diffuse large B-cell lymphoma, Leg type


subject: UNII:AG9MHG098Z

object_name: diffuse large B-cell lymphoma with chronic inflammation


subject: UMLS:C2937463

subject_name: PERFLUTREN 6.52 mg in 1 mL INTRAVENOUS INJECTION, SUSPENSION [Definity]

object_name: ventricular tachycardia


subject: UMLS:C2937463

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: UMLS:C2937463

object_name: continuous electrocardiogram ventricular tachycardia


subject: UMLS:C2937463

object_name: Ventricular Tachycardia by ECG Finding


subject: UMLS:C2937463

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: UMLS:C2937463

object_name: ischemic cardiomyopathy


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: coronary microvascular disorder


subject: CHEBI:71029

subject_name: Ser-Phe


subject: UMLS:C0876942

subject_name: SF Brand of Topical Fluoride


subject: PR:000008534

subject_name: hepatocyte growth factor


subject: PR:000006540

subject_name: dentin matrix acidic phosphoprotein 1


subject: CHEBI:37931

subject_name: Phenothiazine


subject: CHEBI:33853

subject_name: phenols


subject: CHEBI:45716

subject_name: Vorinostat

object_name: brain neoplasm


subject: UMLS:C5417993

subject_name: Porustobart

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417993

object_name: Adult Solid Neoplasm


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IV Gastric Cancer with Metastasis


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Vaso-Occlusive Crisis


subject: CHEBI:9316

object_name: Hemoglobin SS disease with crisis


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Ovarian clear cell carcinoma


subject: GTOPDB:9758

object_name: ovarian clear cell cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: GTOPDB:5635

object_name: abdominal obesity-metabolic syndrome


subject: GTOPDB:5635

object_name: metabolic syndrome X


subject: UMLS:C1141624

subject_name: AM3 (biological)


subject: UMLS:C1141624


subject: CHEBI:45716

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Peripheral vascular disorder due to diabetes mellitus


subject: UMLS:C1099192


subject: CHEMBL.COMPOUND:CHEMBL2109615

subject_name: MRA 003 US

object_name: EXCESS LMW-DNA


subject: CHEBI:94463

object_name: hand, foot and mouth disease


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: atrioventricular block


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: mood (physical finding)


subject: UMLS:C0718247

object_name: Psychological Well Being


subject: UMLS:C0718247

object_name: Cognitive changes


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:2955

subject_name: Azithromycin

object_name: Dry Eye, CTCAE


subject: CHEBI:2955

object_name: Dryness of eye


subject: UMLS:C3197946

subject_name: Tea Tree Oil Topical application Oil

object_name: dry eye syndrome


subject: UMLS:C3197946


subject: UMLS:C3197946


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: HIV infection


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: Sprain of acromioclavicular ligament


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:144903

subject_name: Pro-Arg-Pro


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: hand-foot syndrome


subject: UMLS:C3714638

object_name: Sickle Cell Dactylitis